Next Science Ltd (OTCPK:NXSCF)
$ 0.1496 -0.0329 (-18.03%) Market Cap: 47.70 Mil Enterprise Value: 39.39 Mil PE Ratio: 0 PB Ratio: 2.99 GF Score: 50/100

Half Year 2020 Next Science Ltd Earnings Call Transcript

Aug 26, 2020 / 12:30AM GMT
Release Date Price: $1 (-4.76%)
Operator

Thank you for standing by, and welcome to the Next Science Limited 2020 Half Year Results Conference Call. (Operator Instructions)

I would now like to turn the conference call over to Ms. Judith Mitchell, CEO. Ms. Mitchell, the floor is yours, ma'am.

Judith Mitchell
Next Science Limited - MD, CEO & Director

Good morning, and thank you for joining us for the Next Science half year results call. If you're on the call, I'm guessing you know that Next Science is the company with the answers for biofilms in humans and either the safe removal of the existing biofilm in the bacteria, viruses and fungus, or protecting patients from these biofilms and their associated infections.

We currently have 3 products active in the U.S. market and the launch into the surgical infection prevention market with our new product, XPerience, a no-rinse surgical wash, as soon as it's cleared through the FDA. In fact, overnight, we received additional technical questions from the FDA, very similar to questions our novel technologies have received in the past. And

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot